By now, many Americans are familiar with the Zika virus.
But it’s not just the virus that has left many at risk.
Zika also has created a serious public health crisis for the United States.
As the nation continues to battle a deadly outbreak of Zika in Latin America and the Caribbean, some experts are calling for an overhaul of the nation’s approach to the virus.
For many people, Zika could be the beginning of their own pandemic.
“The first step to addressing the Zika pandemic is recognizing the severity of the pandemic and how devastating it is,” said John H. Daley Jr., a professor of epidemiology and health policy at George Washington University.
“If we can identify a pathway to prevent the spread of the virus, that would be the best way to do it.”
A new approach to combating Zika would include treating the virus and its victims, said the New York City health commissioner, Dr. Thomas Frieden.
In theory, treating a Zika infection would help protect people from the virus’ effects on the brain, which can lead to the death of a person.
But many studies show that it doesn’t prevent the virus from spreading.
Even when patients have the virus in their blood, they can still get the virus after they are treated, according to the National Institutes of Health.
And even if the virus were to be contained in the blood, it would still linger in the body, said David Katz, a senior research scientist at the Johns Hopkins Bloomberg School of Public Health.
Katz and colleagues have found that the risk of brain damage from Zika is much higher in people who have received an organ transplant.
And when transplants are performed, the organ isn’t treated until the patient is at least 70 years old.
That means that in people over 70, the risk is even higher.
That’s because the organs are more likely to be damaged, Katz said.
Some experts argue that treating the brain and spinal cord is an unnecessary risk for people who are older and don’t have the capacity to fight off Zika.
One study found that older people who received an experimental Zika vaccine and who received blood transfusions from a donor aged 60 to 85 were more likely than those with no treatment to have serious brain injuries.
Another study found the vaccine didn’t prevent brain damage in older adults who had been vaccinated against the virus or who had had a recent brain surgery.
But other research has found that treatment with an experimental vaccine could also increase the risk for the virus by causing the immune system to attack healthy tissues.
The CDC and the World Health Organization have called for an urgent halt to the spread, as the virus has already infected more than 7,800 people.
The American Heart Association has also recommended that the country halt all public and private travel to the region.
And the Centers for Disease Control and Prevention has said that the virus may be causing more heart attacks and strokes than previously thought.
This article was produced by The Washington Times as part of the health and science team.